AdaptHealth (NASDAQ:AHCO) Price Target Lowered to $15.00 at Robert W. Baird

AdaptHealth (NASDAQ:AHCO) had its price objective cut by investment analysts at Robert W. Baird from $18.00 to $15.00 in a report released on Monday, Marketbeat.com reports. The firm presently has an “outperform” rating on the stock. Robert W. Baird’s target price would suggest a potential upside of 39.41% from the stock’s current price.

Several other equities analysts have also issued reports on the company. Jefferies Financial Group reaffirmed a “hold” rating and issued a $11.00 target price on shares of AdaptHealth in a report on Monday, April 20th. UBS Group lowered their target price on AdaptHealth from $15.00 to $14.00 and set a “buy” rating on the stock in a research note on Wednesday, May 6th. Truist Financial increased their price target on shares of AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Monday, April 13th. Wall Street Zen raised shares of AdaptHealth from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Finally, Canaccord Genuity Group boosted their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Six equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, AdaptHealth has a consensus rating of “Moderate Buy” and a consensus target price of $13.86.

AdaptHealth Stock Performance

Shares of AHCO stock opened at $10.76 on Monday. The company has a debt-to-equity ratio of 1.21, a current ratio of 0.92 and a quick ratio of 0.71. The firm has a 50-day moving average of $10.66 and a 200-day moving average of $10.62. AdaptHealth has a one year low of $8.51 and a one year high of $13.43. The company has a market cap of $1.46 billion, a P/E ratio of -17.35, a P/E/G ratio of 0.55 and a beta of 1.45.

Insider Transactions at AdaptHealth

In other AdaptHealth news, insider Russell E. Schuster III sold 11,275 shares of the stock in a transaction on Monday, June 1st. The stock was sold at an average price of $10.06, for a total transaction of $113,426.50. Following the sale, the insider owned 136,538 shares in the company, valued at $1,373,572.28. This represents a 7.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is owned by insiders.

Institutional Trading of AdaptHealth

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in AdaptHealth by 4.4% in the 4th quarter. Vanguard Group Inc. now owns 11,768,599 shares of the company’s stock worth $117,215,000 after purchasing an additional 491,106 shares during the period. Deerfield Management Company L.P. lifted its holdings in shares of AdaptHealth by 15.9% in the third quarter. Deerfield Management Company L.P. now owns 11,477,730 shares of the company’s stock worth $102,726,000 after buying an additional 1,572,835 shares in the last quarter. Reinhart Partners LLC. lifted its holdings in shares of AdaptHealth by 10.6% in the fourth quarter. Reinhart Partners LLC. now owns 8,100,785 shares of the company’s stock worth $80,684,000 after buying an additional 773,727 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of AdaptHealth by 8.1% in the first quarter. Dimensional Fund Advisors LP now owns 6,920,973 shares of the company’s stock valued at $82,353,000 after acquiring an additional 518,274 shares during the period. Finally, Principal Financial Group Inc. increased its holdings in AdaptHealth by 25.1% during the 1st quarter. Principal Financial Group Inc. now owns 2,784,316 shares of the company’s stock worth $33,133,000 after acquiring an additional 558,357 shares during the period. 82.67% of the stock is currently owned by institutional investors.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.